Cite
MLA Citation
P Rodriguez-Otero et al.. “B04: COMBINATION OF SUBCUTANEOUS TECLISTAMAB WITH DARATUMUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): RESULTS FROM A PHASE 1B MULTICOHORT STUDY.” HemaSphere, vol. 6, n.d., pp. 7–8. http://access.bl.uk/ark:/81055/vdc_100153435583.0x000033